Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ravi

Showing results (391-400 of 402) with videos related to

Pageof 41
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|October 15, 2011
Evidence for a new two-dimensional C4H-type polymer based on hydrogenated grapheneDanny Haberer, Cristina E Giusca, Ying Wang, et al.
ACS Nano|December 14, 2012
Hybrid carbon nanotube networks as efficient hole extraction layers for organic photovoltaicsG Dinesha M R Dabera, K D G Imalka Jayawardena, M R Ranga Prabhath, et al.
Nanoscale|August 11, 2015
High efficiency air stable organic photovoltaics with an aqueous inorganic contactK D G Imalka Jayawardena, Siying Li, Laurent F Sam, et al.
Bone Marrow Transplantation|February 2, 2022
Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphomaBrian D Friend, Ibrahim N Muhsen, Shreeya Patel, et al.
European Urology|March 15, 2024
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer: An International Multicenter Retrospective StudyManuel Weber, Wolfgang P Fendler, Aravind S Ravi Kumar, et al.
Diabetes|December 4, 2021
Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin Is a Novel Risk Factor for Cardiometabolic DisordersPrasanna K R Allu, Malapaka Kiranmayi, Sromona D Mukherjee, et al.
The Lancet. Oncology|October 21, 2025
Lutetium-177 [<sup>177</sup>Lu]Lu-PSMA-I&T plus radium-223 in patients with metastatic castration-resistant prostate cancer (AlphaBet): an interim analysis of the investigator-initiated, single-centre, single-arm, phase 1/2 trialLouise Kostos, James P Buteau, Jing Xie, et al.
The Lancet. Oncology|April 2, 2026
[<sup>177</sup>Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 studyShahneen Sandhu, Anthony M Joshua, Louise Emmett, et al.
Asian Journal of Psychiatry|February 3, 2023
Growth trajectories for executive and social cognitive abilities in an Indian population sample: Impact of demographic and psychosocial determinantsEesha Sharma, G S Ravi, Keshav Kumar, et al.
The Lancet. Oncology|July 5, 2025
First-in-human results of terbium-161 [<sup>161</sup>Tb]Tb-PSMA-I&T dual beta-Auger radioligand therapy in patients with metastatic castration-resistant prostate cancer (VIOLET): a single-centre, single-arm, phase 1/2 studyJames P Buteau, Louise Kostos, Price A Jackson, et al.
Pageof 41

Showing results (391-400 of 402) with videos related to

Sort By:
Pageof 41
Advanced Materials (Deerfield Beach, Fla.)|October 15, 2011
Evidence for a new two-dimensional C4H-type polymer based on hydrogenated grapheneDanny Haberer, Cristina E Giusca, Ying Wang, et al.
ACS Nano|December 14, 2012
Hybrid carbon nanotube networks as efficient hole extraction layers for organic photovoltaicsG Dinesha M R Dabera, K D G Imalka Jayawardena, M R Ranga Prabhath, et al.
Nanoscale|August 11, 2015
High efficiency air stable organic photovoltaics with an aqueous inorganic contactK D G Imalka Jayawardena, Siying Li, Laurent F Sam, et al.
Bone Marrow Transplantation|February 2, 2022
Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphomaBrian D Friend, Ibrahim N Muhsen, Shreeya Patel, et al.
European Urology|March 15, 2024
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Disease Extent and Overall Survival of Patients with High-risk Nonmetastatic Castration-resistant Prostate Cancer: An International Multicenter Retrospective StudyManuel Weber, Wolfgang P Fendler, Aravind S Ravi Kumar, et al.
Diabetes|December 4, 2021
Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin Is a Novel Risk Factor for Cardiometabolic DisordersPrasanna K R Allu, Malapaka Kiranmayi, Sromona D Mukherjee, et al.
The Lancet. Oncology|October 21, 2025
Lutetium-177 [<sup>177</sup>Lu]Lu-PSMA-I&T plus radium-223 in patients with metastatic castration-resistant prostate cancer (AlphaBet): an interim analysis of the investigator-initiated, single-centre, single-arm, phase 1/2 trialLouise Kostos, James P Buteau, Jing Xie, et al.
The Lancet. Oncology|April 2, 2026
[<sup>177</sup>Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 studyShahneen Sandhu, Anthony M Joshua, Louise Emmett, et al.
Asian Journal of Psychiatry|February 3, 2023
Growth trajectories for executive and social cognitive abilities in an Indian population sample: Impact of demographic and psychosocial determinantsEesha Sharma, G S Ravi, Keshav Kumar, et al.
The Lancet. Oncology|July 5, 2025
First-in-human results of terbium-161 [<sup>161</sup>Tb]Tb-PSMA-I&T dual beta-Auger radioligand therapy in patients with metastatic castration-resistant prostate cancer (VIOLET): a single-centre, single-arm, phase 1/2 studyJames P Buteau, Louise Kostos, Price A Jackson, et al.
Pageof 41